Home/Filings/4/0001209191-18-041678
4//SEC Filing

NIEMANN BRADLEY V. 4

Accession 0001209191-18-041678

CIK 0000884624other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:43 PM ET

Size

16.8 KB

Accession

0001209191-18-041678

Insider Transaction Report

Form 4
Period: 2018-07-02
NIEMANN BRADLEY V.
President Biostim
Transactions
  • Exercise/Conversion

    Common Stock

    2018-07-03$21.78/sh+6,250$136,12538,242 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-07-035,0000 total
    Exercise: $27.37From: 2017-07-01Exp: 2023-07-01Common Stock (5,000 underlying)
  • Award

    Common Stock

    2018-07-02+2,98926,992 total
  • Exercise/Conversion

    Common Stock

    2018-07-03$27.37/sh+5,000$136,85031,992 total
  • Sale

    Common Stock

    2018-07-03$56.94/sh9,100$518,12629,142 total
  • Sale

    Common Stock

    2018-07-03$57.35/sh2,150$123,30926,992 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-07-036,2500 total
    Exercise: $21.78From: 2017-09-26Exp: 2023-09-26Common Stock (6,250 underlying)
Footnotes (4)
  • [F1]Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 2, 2018.
  • [F2]The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on November 9,2017.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.27 to $57.25, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.27 to $57.45, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Issuer

ORTHOFIX INTERNATIONAL N V

CIK 0000884624

Entity typeother

Related Parties

1
  • filerCIK 0001669839

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:43 PM ET
Size
16.8 KB